DNM1L and Alzheimer disease: Furthermore, postmortem brain samples from Alzheimer’s disease (AD) patients presented higher levels of S-nitrosylated DRP1 when compared to control samples or samples from patients suffering from Parkinson’s disease (PD) [99].